STAT3

Aluda has discovered and patented a series of highly selective small molecule compounds which may offer multiple, newly elucidated roles that enhance the value of targeting both for its activation against cancers, and its inhibition against autoimmune disorders.

This document was printed from http://www.aludapharm.com/science/stat3.html